Latest Europe News

IMDEX Limited has delivered a record 3Q FY26 revenue increase of 29% in constant currency, fueled by strong global demand, strategic acquisitions, and AI-enabled mining technology solutions.

Mont Royal Resources reveals one of the largest fluorspar deposits globally at its Ashram Project, supported by historical test work showing high-grade acid-spar concentrate potential and shifting global supply dynamics.

Green Technology Metals (ASX: GT1) has initiated a fully underwritten $4 million entitlement offer to fund the next phase of its Seymour Lithium Project, alongside a $7 million placement subject to shareholder approval.

PYC Therapeutics presented Phase 1/2 data at ARVO 2026 showing encouraging safety and efficacy signals for its RNA therapies targeting rare genetic eye diseases Retinitis Pigmentosa type 11 and Autosomal Dominant Optic Atrophy.

Imricor Medical Systems has secured A$60 million through a placement to fund its US commercial rollout, regulatory approvals, and clinical programs, boosting its cash reserves to nearly A$103 million.

Terrain Minerals has locked in $1.5 million through a placement to accelerate drilling and resource studies at its Smokebush Lightning gold project, Lort River rare earths, and Carlindie lithium/gold projects.

Energy Transition Minerals has released a JORC-compliant Mineral Resource Estimate for its Penouta tin-tantalum-niobium mine in Spain, reinforcing its strategic role in Europe's critical minerals supply chain and setting the stage for a project restart.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

Hastings Technology Metals secures 49% of a Thai hydromet plant, aiming for Q4 2026 production using African monazite feedstock, setting a path for early cash flow ahead of Yangibana.

RocketBoots has secured a significant A$3.3 million activation contract with a tier-one multinational retailer and reported over 50% growth in its early sales pipeline, supported by a strong cash position of A$5 million.

Evion Group has secured key approvals from Madagascar’s Ministry of Mines to convert exploration permits into mining permits for its Maniry Graphite Project, backed by significant EU funding and US trade initiatives. Meanwhile, its Indian joint venture progresses a major graphite plant expansion to meet growing demand.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.